OrbiMed’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,578
| Closed | -$1.41M | – | 165 |
|
|
2020
Q3 | $1.41M | Sell |
10,578
-8,000
| -43% | -$1.07M | 0.02% | 137 |
|
|
2020
Q2 | $3.13M | Hold |
18,578
| – | – | 0.04% | 122 |
|
|
2020
Q1 | $2.67M | Hold |
18,578
| – | – | 0.04% | 118 |
|
|
2019
Q4 | $6.13M | Hold |
18,578
| – | – | 0.09% | 95 |
|
|
2019
Q3 | $9.29M | Hold |
18,578
| – | – | 0.18% | 78 |
|
|
2019
Q2 | $11.3M | Hold |
18,578
| – | – | 0.17% | 84 |
|
|
2019
Q1 | $11.3M | Hold |
18,578
| – | – | 0.18% | 83 |
|
|
2018
Q4 | $6.78M | Hold |
18,578
| – | – | 0.13% | 92 |
|
|
2018
Q3 | $12.5M | Buy |
18,578
+2,900
| +18% | +$1.96M | 0.15% | 103 |
|
|
2018
Q2 | $13.6M | Hold |
15,678
| – | – | 0.16% | 103 |
|
|
2018
Q1 | $19.7M | Hold |
15,678
| – | – | 0.24% | 81 |
|
|
2017
Q4 | $23.4M | Hold |
15,678
| – | – | 0.3% | 75 |
|
|
2017
Q3 | $32.1M | Hold |
15,678
| – | – | 0.31% | 76 |
|
|
2017
Q2 | $41.1M | Buy |
15,678
+8,966
| +134% | +$23.5M | 0.43% | 64 |
|
|
2017
Q1 | $20.1M | Hold |
6,712
| – | – | 0.23% | 78 |
|
|
2016
Q4 | $10M | Buy |
6,712
+1,452
| +28% | +$2.16M | 0.13% | 89 |
|
|
2016
Q3 | $9.27M | Hold |
5,260
| – | – | 0.11% | 99 |
|
|
2016
Q2 | $9.86M | Hold |
5,260
| – | – | 0.1% | 89 |
|
|
2016
Q1 | $11.8M | Hold |
5,260
| – | – | 0.12% | 83 |
|
|
2015
Q4 | $12.7M | Hold |
5,260
| – | – | 0.11% | 86 |
|
|
2015
Q3 | $12.5M | Buy |
+5,260
| New | +$12.5M | 0.13% | 85 |
|